COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Latest 20-F/A SEC Filings
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

IMMUNE NETWORK RESEARCH LTD, 20-F/A, 2000-08-30


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission